Digital Long-term Follow-up of Patients With Coronary Artery Disease

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorOslo University Hospital

About this trial

The need for better follow-up of AMI patients combined with recent developments in the digital area prompted the Department of Cardiology (HJE) at Oslo University Hospital (OUS) Ullevål, in collaboration with the Department of Digital Health Research (DIG) at OUS to develop a digital solution for long-term follow-up after AMI. The overall goal of the digital solution is to increase knowledge and awareness about important lifestyle measures and CV risk factors in patients who have survived an AMI, and to make it easy for the patients to monitor their own risk factors and attainment of treatment goals during long-term follow-up. Further, the HeartCheck seeks to provide guidance to ensure medication adherence. In this project, we study whether this newly developed app (HeartCheck), through education, regular reminders and easily understandable goals for secondary prevention, can improve risk factor control and drug adherence during long-term follow-up after AMI. A randomized controlled trial (RCT) is the chosen study design, being the gold standard for testing effectiveness of interventions.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

>18 years of age

survived a recent (<30 days) AMI and/or PCI

access to a smartphone or tablet

signed written informed consent

Disqualifiers

patient does not understand Norwegian

patient is unable to comply with the study procedures due to severe comorbidities or high age

Trial design

Design model

Parallel

Treatments tested in this trial

  • "HeartCheck"

    Device

    a digital application developed specifically for patient support during follow-up after acute myocardial infarction or PI for stable coronary artery disease

Treatment groups

630 Participants
are divided into 2 treatment groups
Group A: Use of a digital application for follow-upExperimental treatment 1 intervention
Group B: Usual careNo intervention 0 interventions

Trial outcomes

Primary outcomes

1

Proportion of patients fulfilling 4 evidence-based goals for risk factor control

Proportion of patients who fulfills all of the following: 1) BP \<130/80 mmHg, 2) LDL-cholesterol \<1.4 mmol/l, 3) HbA1c \<53mmol/mol, 4) No smoking

Time frame
12 months after inclusion in the study

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Oslo University Hospital

Lead sponsor

Sorlandet Hospital HF

Collaborator